Novo Nordisk raises full-year guidance again as US sales of Wegovy, Ozempic fly - Reuters
- Novo Nordisk raises full-year guidance again as US sales of Wegovy, Ozempic fly Reuters
- Novo Nordisk hikes outlook on soaring demand for Wegovy, Ozempic CNBC
- Novo Nordisk boosts sales and profit outlook, buoyed by Ozempic and Wegovy MarketWatch
- High-flying Novo Nordisk again dials up its 2023 sales and profit expectations FiercePharma
- View Full Coverage on Google News